The differential effect of RB1 loss on p16INK4a expression in luminal B versus basal-like tumour cells implicates other transcription factors in addition to pRb-E2F in the regulation of this CDK inhibitor in luminal tumours. This evidence concerns the gene RB1 and neoplasm.